Datar Cancer Genetics Unveils Exacta AI: A Revolutionary AI-Driven Cancer Treatment Platform

Metropolis Healthcare Partners with Roche to Launch Self-Sampling HPV DNA Test for Cervical Cancer Screening in India

Union Budget 2025: Full Exemption from Basic Customs Duty (BCD) for 36 Lifesaving Drugs

Dr. Jitendra Singh Inaugurates Centre for Advanced Genomics & Precision Medicine at AIIMS Jammu

Union Budget 2025-26: Key Healthcare Measures for Cancer Care and Access to Life-Saving Drugs

FDA Approves Roche’s PATHWAY HER2 Test for Identifying HER2-Ultralow Breast Cancer Patients Eligible for ENHERTU

Bristol Myers Squibb’s Breyanzi® Receives CHMP Recommendation for Relapsed or Refractory Follicular Lymphoma in the EU

NHS to Offer Groundbreaking Gene Therapy for Sickle Cell Disease

Quibim Secures $50M Series A to Advance AI-Powered Imaging for Precision Medicine

Apollo Hospitals Unveils Advanced Oncology Facility in Chennai

Beckman Coulter’s Alzheimer’s Blood Test Receives FDA Breakthrough Device Designation

ANGLE Announces Breakthrough Dual CTC-DNA and ctDNA Analysis with Illumina’s NGS Solution

Diatech Pharmacogenetics and Merck Expand Collaboration to Enhance RAS Biomarker Testing in MEA Region

DCG Unveils AI-Powered Video-Reporting for Personalized Chemotherapy Selection

FDA Approves Monthly Maintenance Dosing for LEQEMBI® in Alzheimer’s Treatment

Home
/
update
/
details

Goa Revolutionizes Cancer Care with AI-driven Screening and Treatment Initiatives

NextEdge Admin

12 May 2024

1 min 44 sec

Goa’s Health Minister, Vishwajit Rane, recently announced a significant stride in healthcare innovation. Patients across all district hospitals and primary health centers (PHCs) in the state will soon have access to Artificial Intelligence-driven lung cancer screening tools. Rane emphasized the state’s commitment to comprehensive cancer care, highlighting its leadership in the field.

With district hospitals in Mapusa and Margao, Goa is set to pioneer AI-based screening for lung cancer, ensuring early detection and timely intervention. Rane also underscored the state’s proactive approach by mentioning free breast cancer screenings available at state-run PHCs, facilitating crucial early diagnoses.

Moreover, in a bid to enhance accessibility to advanced treatments, the Goa Medical College offers the Pertuzumab-Trastuzumab combo therapy free of cost to patients diagnosed with HER2+ breast cancer, a testament to the state’s dedication to holistic patient care.

In a groundbreaking collaboration with the Tata Memorial, Goa is poised to establish a state-of-the-art multi-super-specialty cancer hospital, promising top-tier care to its residents. This initiative further solidifies the state’s position as a frontrunner in advancing cancer care methodologies.